Top compounds associated with response to ALAS2


Feature Type Standardized
Nominal ANOVA
mRNA AKT inhibitor VIII GDSC1000 pan-cancer AAC -0.0042 0.9
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.0038 0.9
mRNA Roscovitine GDSC1000 pan-cancer AAC -0.0063 0.9
mRNA canertinib CTRPv2 pan-cancer AAC -0.0044 0.9
mRNA austocystin d CTRPv2 pan-cancer AAC -0.0045 0.9
mRNA marinopyrrole A CTRPv2 pan-cancer AAC 0.0051 0.9
mRNA AZD0530 FIMM pan-cancer AAC -0.02 0.9
mRNA Nutlin-3 CTRPv2 pan-cancer AAC -0.004 0.9
mRNA GDC-0449 FIMM pan-cancer AAC -0.021 0.9
mRNA 17-AAG GDSC1000 pan-cancer AAC 0.0035 0.9
Download CSV